Clinical Trial Update: Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on a standardized Centella Asiatica extract for temporomandibular disorder across Phase 2 and Phase 3, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorder

Drugs mentioned

• Centella Asiatica extract (standardized) (Centella asiatica extract)

Snippet

Sponsor: Chulalongkorn University | Conditions: Temporomandibular Disorder | Phase 2, Phase 3 | Status: COMPLETED